Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8+ T-cell memory

被引:103
作者
Christensen, JP [1 ]
Doherty, PC [1 ]
Branum, KC [1 ]
Riberdy, JM [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA
关键词
D O I
10.1128/JVI.74.24.11690-11696.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The recall of CD8(+) T-cell memory established by infecting H-2(b) mice with an HINT influenza A virus provided a measure of protection against an extremely virulent H7N7 virus. The numbers of CD8(+) effector and memory T cells specific for the shared, immunodominant (DNP366)-N-b epitope were greatly increased subsequent to the H7N7 challenge, and though lung titers remained as high as those in naive controls for 5 days or more, the virus was cleared more rapidly. Expanding the CD8(+) memory T-cell pool (< 0.5 to > 10%) by sequential priming with two different influenza A viruses (H3N2 --> H1N1) gave much better protection. Though the H7N7 virus initially grew to equivalent titers in the lungs of naive and double-primed mice, the replicative phase was substantially controlled within 3 days. This tertiary H7N7 challenge caused little increase in the magnitude of the CD8(+) (DNP366+)-N-b T-cell pool, and only a portion of the memory population in the lymphoid tissue could be shown to proliferate. The great majority of the CD8(+) (DNP366+)-N-b set that localized to the infected respiratory tract had, however, cycled at least once, though recent cell division was shown not to be a prerequisite for T-cell extravasation. The selective induction of CD8(+) T-cell memory can thus greatly limit the damage caused by a virulent influenza A virus, with the extent of protection being directly related to the number of available responders. Furthermore, a large pool of CD8(+) memory T cells may be only partially utilized to deal with a potentially lethal influenza infection.
引用
收藏
页码:11690 / 11696
页数:7
相关论文
共 41 条
[1]  
ALLAN W, 1990, J IMMUNOL, V144, P3980
[2]   EFFICACY OF INFLUENZA HEMAGGLUTININ AND NUCLEOPROTEIN AS PROTECTIVE ANTIGENS AGAINST INFLUENZA-VIRUS INFECTION IN MICE [J].
ANDREW, ME ;
COUPAR, BEH .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 28 (01) :81-85
[3]  
Banchereau J, 1997, TRANSFUS SCI, V18, P313
[4]   A previously unrecognized H-2Db-restricted peptide prominent in the primary influenza A virus-specific CD8+ T-cell response is much less apparent following secondary challenge [J].
Belz, GT ;
Xie, WD ;
Altman, JD ;
Doherty, PC .
JOURNAL OF VIROLOGY, 2000, 74 (08) :3486-3493
[5]   HETEROTYPIC IMMUNE MICE LOSE PROTECTION AGAINST INFLUENZA-VIRUS INFECTION WITH SENESCENCE [J].
BENDER, BS ;
SMALL, PA .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (04) :873-880
[6]   Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus [J].
Claas, ECJ ;
Osterhaus, ADME ;
van Beek, R ;
De Jong, JC ;
Rimmelzwaan, GF ;
Senne, DA ;
Krauss, S ;
Shortridge, KF ;
Webster, RG .
LANCET, 1998, 351 (9101) :472-477
[7]   Effective immunization with live attenuated influenza A virus can be achieved in early infancy [J].
Clements, ML ;
Makhene, MK ;
Karron, RA ;
Murphy, BR ;
Steinhoff, MC ;
Subbarao, K ;
Wilson, MH ;
Wright, PF .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (01) :44-51
[8]  
DOHERTY PC, 1973, AM J PATHOL, V73, P607
[9]   Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney blood bank cohort patients infected with nef-defective HIV type 1 [J].
Dyer, WB ;
Ogg, GS ;
Demoitie, MA ;
Jin, X ;
Geczy, AF ;
Rowland-Jones, SL ;
McMichael, AJ ;
Nixon, DF ;
Sullivan, JS .
JOURNAL OF VIROLOGY, 1999, 73 (01) :436-443
[10]   Virus-specific CD8+ T cells in primary and secondary influenza pneumonia [J].
Flynn, KJ ;
Belz, GT ;
Altman, JD ;
Ahmed, R ;
Woodland, DL ;
Doherty, PC .
IMMUNITY, 1998, 8 (06) :683-691